These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17530212)

  • 1. [MR spectroscopy in brain tumors].
    Papanagiotou P; Backens M; Grunwald IQ; Farmakis G; Politi M; Roth C; Reith W
    Radiologe; 2007 Jun; 47(6):520-9. PubMed ID: 17530212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance spectroscopy of brain tumours].
    Harting I; Jost G; Hacke N; Hartmann M
    Nervenarzt; 2005 Apr; 76(4):403-17. PubMed ID: 15349736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy)].
    Essig M; Giesel F; Stieltjes B; Weber MA
    Radiologe; 2007 Jun; 47(6):513-9. PubMed ID: 17505814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain.
    Bruggers CS; Moore K
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e341-5. PubMed ID: 24072251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MR spectroscopy in neurooncology.
    Kozić D; Ostojić J; Bjelan M; Koprivšek K
    Prilozi; 2012; 33(1):425-33. PubMed ID: 23037188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
    Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
    J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.
    Wagnerova D; Jiru F; Dezortova M; Vargova L; Sykova E; Hajek M
    MAGMA; 2009 Feb; 22(1):19-31. PubMed ID: 18953587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeatability of edited lactate and other metabolites in astrocytoma at 3T.
    McLean MA; Sun A; Bradstreet TE; Schaeffer AK; Liu H; Iannone R; Herman G; Railkar RA; Joubert I; Gillard JH; Price SJ; Griffiths JR
    J Magn Reson Imaging; 2012 Aug; 36(2):468-75. PubMed ID: 22535478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of MRS in the evaluation of focal malignant brain lesions.
    Delorme S; Weber MA
    Cancer Imaging; 2006 Jun; 6(1):95-9. PubMed ID: 16829470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumors.
    Kim JH; Chang KH; Na DG; Song IC; Kim SJ; Kwon BJ; Han MH
    Korean J Radiol; 2006; 7(3):156-61. PubMed ID: 16969044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings.
    Kocaoglu M; Ors F; Bulakbasi N; Onguru O; Ulutin C; Secer HI
    Magn Reson Imaging; 2009 Apr; 27(3):434-40. PubMed ID: 18789624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
    Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
    Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.